You Tian, Zhang Wentao, Li Wei, Zhang Xintao, Jiang Xiaocheng, Zuo Jianwei, Zhou Ri, Chen Juan, Jiang Changqing
Center of Sports Medicine and Rehabilitation, Peking University Shenzhen Hospital, Shenzhen Guangdong, 518000, P.R.China.
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2021 Aug 15;35(8):935-940. doi: 10.7507/1002-1892.202103088.
The 2020 Management of Glenohumeral Joint Osteoarthritis Evidence-Based Clinical Practice Guideline which was prepared by the American Academy of Orthopaedic Surgeons (AAOS) were publicated on October 2020. The guideline involves the following 8 chapters: drug therapy and injectable biologics, physical therapy and non-surgical treatments, radiographs, prognostic factors, surgical treatments, intraoperative hemostasis measure (tranexamic acid), management of supraspinatus tears, multimodal pain management and discharge. In this paper, the guideline is interpreted to provide cutting-edge information for domestic glenohumeral joint osteoarthritis researchers.
由美国矫形外科医师学会(AAOS)制定的《2020年肩肱关节骨关节炎循证临床实践指南》于2020年10月发布。该指南涵盖以下8章:药物治疗与注射用生物制剂、物理治疗与非手术治疗、X线片、预后因素、手术治疗、术中止血措施(氨甲环酸)、冈上肌撕裂的处理、多模式疼痛管理及出院。本文对该指南进行解读,以为国内肩肱关节骨关节炎研究人员提供前沿信息。